title: Positive chronotropic activity of bradykinin in the pithed normotensive rat.
abstract: The positive chronotropic effect of bradykinin was investigated in the pithed rat preparation. Cumulative treatment with bradykinin (0.20 nmol/kg-6.59 mumol/kg, intravenous [i.v.]) caused a dose-dependent increase in heart rate (HR) by a maximum of 80 +/- 3.3 beats min-1. In contrast, the active metabolite of bradykinin and selective bradykinin B1-receptor agonist, [des-Arg9]-bradykinin did not influence the spontaneous frequency of beating. Propranolol alone reduced the bradykinin-induced increase in HR and a combination of propranolol with prazosin abolished the chronotropic effect of bradykinin. The selective bradykinin B2 receptor antagonist. Hoe 140, dose-dependently shifted the dose-response curves of bradykinin to the right, whereas the bradykinin B1 receptor antagonist, des-Arg10-[Leu9]-kallidin proved ineffective. From our experiments it may be concluded that bradykinin induces tachycardia in the pithed rat primarily by stimulating the sympathetic ganglia leading to the release of noradrenaline, which subsequently activates cardiac beta 1-adrenoceptors. The bradykinin-induced chronotropic effect is mediated by bradykinin B2-receptors, whereas B1-receptors appear not to be involved.
authors.affiliation: Departamento de Farmacología, Universidad de Las Palmas, Las Palmas de Gran Canaria, Spain.
authors.forename: J F
authors.initials: JF
authors.lastname: Loro
authors.forename: J
authors.initials: J
authors.lastname: Zhang
authors.forename: M
authors.initials: M
authors.lastname: Pfaffendorf
authors.forename: P A
authors.initials: PA
authors.lastname: van Zwieten
mesh_terms: D000315:Adrenalectomy; D058668:Adrenergic alpha-1 Receptor Antagonists; D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D001920:Bradykinin / Q000031:analogs & derivatives / Q000378:metabolism / Q000494:pharmacology*; D065168:Bradykinin Receptor Antagonists; D003655:Decerebrate State; D006339:Heart Rate / Q000187:drug effects*; D007609:Kallidin / Q000031:analogs & derivatives / Q000494:pharmacology; D008297:Male; D051381:Rats; D017208:Rats, Wistar; D043783:Receptor, Bradykinin B1; D043782:Receptor, Bradykinin B2; D011941:Receptors, Adrenergic / Q000187:drug effects
chemical_list: D058668:Adrenergic alpha-1 Receptor Antagonists; D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D065168:Bradykinin Receptor Antagonists; D043783:Receptor, Bradykinin B1; D043782:Receptor, Bradykinin B2; D011941:Receptors, Adrenergic; C082229:bradykinin, Lys-Leu(8)-desArg(9)-; D007609:Kallidin; C065679:icatibant; D001920:Bradykinin